[Form 4] EGAIN Corp Insider Trading Activity

Rhea-AI Filing Summary

eGain (EGAN) insider activity: the Chief Financial Officer reported Form 4 transactions on 11/03/2025. He exercised 5,000 stock options at $2.5 and sold 5,000 common shares at an average price of $14.44 pursuant to a Rule 10b5-1 plan adopted on March 8, 2024.

After these trades, he directly holds 129,187 common shares and 38,000 stock options remain beneficially owned. The reported sales were executed across multiple trades between $14.23 and $14.74.

Insights

Insider transactions analyst

Routine Form 4: option exercise and matched sale under 10b5-1.

The CFO exercised 5,000 options at $2.5 and sold 5,000 shares at a reported average of $14.44 on 11/03/2025. The filing notes execution under a Rule 10b5-1 trading plan adopted on March 8, 2024, indicating a pre-set schedule.

Post-transaction, direct holdings are 129,187 shares, with 38,000 options remaining. The sale price range was $14.23–$14.74. This appears administrative and does not, by itself, alter the company’s fundamentals.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SMIT ERIC

(Last) (First) (Middle)

1252 BORREGAS AVENUE

(Street)

SUNNYVALE CA 94089

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EGAIN Corp [ EGAN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
11/03/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/03/2025(1)		M		5,000	A	$2.5	134,187	D
Common Stock	11/03/2025(1)		S		5,000	D	$14.44(2)	129,187	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$2.5	11/03/2025		M			5,000	(3)	09/19/2027	Common Stock	5,000	$0	38,000	D

Explanation of Responses:

1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2024.

2. Represents actual price. These shares were sold in multiple transactions ranging in price from $14.23 to $14.74. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.

3. The options, representing a right to purchase a total of 112,000 shares, became exercisable beginning on September 19, 2017, and is now fully vested.

	/s/ Eric Smit	11/05/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did eGain (EGAN) disclose?

The CFO exercised 5,000 options at $2.5 and sold 5,000 shares at an average $14.44 on 11/03/2025.

Was the eGain (EGAN) sale under a Rule 10b5-1 plan?

Yes. The trades were made pursuant to a Rule 10b5-1 plan adopted on March 8, 2024.

What are the CFO’s holdings after the reported eGain (EGAN) trades?

He directly owns 129,187 common shares and has 38,000 stock options beneficially owned.

What was the price range of the eGain (EGAN) share sales?

Multiple trades occurred between $14.23 and $14.74.

What option grant did the CFO exercise at eGain (EGAN)?

An employee stock option with a $2.5 exercise price; 5,000 underlying shares were exercised on 11/03/2025.